NCT07460986
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07460986
Title A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma. (BEXAR)
Acronym BEXAR
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Institut Català d' Oncologia Badalona (ICO) NOT_YET_RECRUITING Badalona Spain Details
Hospital de Cruces NOT_YET_RECRUITING Barakaldo Spain Details
Hospital Universitari Vall D'Hebron (VHIO) RECRUITING Barcelona Spain Details
Hospital Clínico San Carlos RECRUITING Madrid Spain Details
Hospital Universitario Doce de Octubre RECRUITING Madrid Spain Details
Hospital Universitario Gregorio Marañón NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario La Paz NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario Virgen de la Victoria RECRUITING Málaga Spain Details
Hospital Universitario de Canarias NOT_YET_RECRUITING San Cristóbal de La Laguna Spain Details
Hospital Universitario Virgen del Rocío NOT_YET_RECRUITING Seville Spain Details
Hospital Universitario Miguel Servet RECRUITING Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field